Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. (Q53553054)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. |
scientific article |
Statements
Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. (English)
1 reference
Ralph G Zinner
1 reference
John Nemunaitis
1 reference
Irene Eiseman
1 reference
Hyung Ju C Shin
1 reference
Stephen C Olson
1 reference
James Christensen
1 reference
Xin Huang
1 reference
Peter F Lenehan
1 reference
Nicholas J Donato
1 reference
Dong M Shin
1 reference
1 May 2007
1 reference
13
1 reference
10
1 reference
3006-3014
1 reference
Identifiers
1 reference